Publications HAL de la structure 166422
ref_biblio
Serge Perrot, Anne-Priscille Trouvin. Re-thinking the perception of long-term opioid use in RMDs. Nature Reviews Rheumatology, 2023, 19 (11), ⟨10.1038/s41584-023-01022-3⟩. ⟨hal-04278045⟩
Accès au bibtex
BibTex
ref_biblio
Luis Garcia-Larrea, Didier Bouhassira. Personalized pain management: Ready for it?. European Journal of Pain, 2023, 27 (9), pp.1043-1043. ⟨10.1002/ejp.2168⟩. ⟨inserm-04238847⟩
Accès au bibtex
BibTex
ref_biblio
Andrea Truini, Katina Aleksovska, Christopher Anderson, Nadine Attal, Ralf Baron, et al.. Joint European Academy of Neurology–European Pain Federation–Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment. European Journal of Neurology, 2023, 30 (8), pp.2177-2196. ⟨10.1111/ene.15831⟩. ⟨inserm-04238854⟩
Accès au texte intégral et bibtex
https://inserm.hal.science/inserm-04238854/file/Euro%20J%20of%20Neurology%20-%202023%20-%20Truini.pdf BibTex
ref_biblio
Nadine Attal, Didier Bouhassira, Lesley Colvin. Advances and challenges in neuropathic pain: a narrative review and future directions. British Journal of Anaesthesia, 2023, 131 (1), pp.79-92. ⟨10.1016/j.bja.2023.04.021⟩. ⟨inserm-04238857⟩
Accès au bibtex
BibTex
ref_biblio
Catharina Gerritdina Faber, Nadine Attal, Giuseppe Lauria, Robert H. Dworkin, Roy L. Freeman, et al.. Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal study. EClinicalMedicine, 2023, 59, ⟨10.1016/j.eclinm.2023.101971⟩. ⟨hal-04106352⟩
Accès au texte intégral et bibtex
https://hal.science/hal-04106352/file/1-s2.0-S2589537023001487-main.pdf BibTex
ref_biblio
Valéria Martinez, Mikhail A. Dziadzko, Juan Tamayo, Sébastien Schitter, Leah Guichard, et al.. Chronic pain characteristics in COVID-19 survivors after an ICU stay. A cross-sectional study. Anaesthesia Critical Care & Pain Medicine, 2023, 42 (6), ⟨10.1016/j.accpm.2023.101267⟩. ⟨hal-04190820⟩
Accès au texte intégral et bibtex
https://hal.science/hal-04190820/file/main%20%281%29.pdf BibTex
ref_biblio
Juliane Sachau, Manon Sendel, Marie Péchard, Kathrin Schnabel, Iris Schmieg, et al.. Patient Reported Outcome Measures in Chronic Neuropathic Pain Clinical Trials – A Systematic Literature Review. Journal of Pain, 2023, 24 (1), pp.38-54. ⟨10.1016/j.jpain.2022.09.003⟩. ⟨hal-03949607⟩
Accès au texte intégral et bibtex
https://hal.science/hal-03949607/file/PIIS1526590022003935.pdf BibTex
ref_biblio
Didier Bouhassira, Frédéric Adam. Reply to Andrassy and Mukhdomi. Pain, 2023, 164 (9), ⟨10.1097/j.pain.0000000000002988⟩. ⟨hal-04190821⟩
Accès au bibtex
BibTex
ref_biblio
A. Spagna, Nadine Attal. Botulinum toxin A and neuropathic pain: An update. Toxicon, 2023, 232, ⟨10.1016/j.toxicon.2023.107208⟩. ⟨hal-04190822⟩
Accès au bibtex
BibTex
ref_biblio
Nadine Attal, Didier Bouhassira, Lesley A. Colvin. Advances and challenges in neuropathic pain: a narrative review and future directions. British Journal of Anaesthesia, 2023, 131 (1), pp.79-92. ⟨10.1016/j.bja.2023.04.021⟩. ⟨hal-04191628⟩
Accès au bibtex
BibTex